We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · November 19, 2022

Intravenous Methylprednisolone Pulses in Hospitalized Patients With Severe COVID-19 Pneumonia

The European Respiratory Journal


Additional Info

The European Respiratory Journal
Intravenous methylprednisolone pulses in hospitalised patients with severe COVID-19 pneumonia: a double-blind, randomised, placebo-controlled trial
Eur. Respir. J. 2022 Oct 01;60(4)2200025, C Salvarani, M Massari, M Costantini, DF Merlo, GL Mariani, P Viale, S Nava, G Guaraldi, G Dolci, L Boni, L Savoldi, P Bruzzi, C Turrà, M Catanoso, AM Marata, C Barbieri, A Valcavi, F Franzoni, S Cavuto, G Mazzi, R Corsini, F Trapani, A Bartoloni, E Barisione, C Barbieri, GJ Burastero, A Pan, W Inojosa, R Scala, C Burattini, F Luppi, M Codeluppi, KE Tarek, G Cenderello, M Salio, G Foti, R Dongilli, G Bajocchi, EA Negri, G Ciusa, G Fornaro, I Bassi, L Zammarchi, T Aloè, N Facciolongo

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading